241 related articles for article (PubMed ID: 28619389)
1. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome.
Kabel AM; Al-Shehri AH; Al-Talhi RA; Abd Elmaaboud MA
Chem Biol Interact; 2017 Aug; 273():190-199. PubMed ID: 28619389
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats.
Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T
J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary.
Rezvanfar MA; Saadat S; Shojaei Saadi HA; Mansoori P; Saeedi S; Gooshe M; Baeeri M; Abdollahi M
Theriogenology; 2015 Apr; 83(6):968-77. PubMed ID: 25557188
[TBL] [Abstract][Full Text] [Related]
4. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M
Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Selenium Nanoparticles on Letrozole-Induced Polycystic Ovarian Syndrome in Female Wistar Rats.
Butt MA; Shafique HM; Mustafa M; Moghul NB; Munir A; Shamas U; Tabassum S; Kiyani MM
Biol Trace Elem Res; 2023 Nov; 201(11):5213-5229. PubMed ID: 36694071
[TBL] [Abstract][Full Text] [Related]
7. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
Kavousipour S; Koohnavard F; Shahbazi B; Eftekhar E; Ahmadi K
Biomed Pharmacother; 2024 May; 174():116504. PubMed ID: 38552442
[TBL] [Abstract][Full Text] [Related]
8. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Action of Virgin Coconut Oil and Clomiphene in Reversing Endocrine Dysregulation in Letrozole-Model of Polycystic Ovarian Syndrome in Rats: Role of Nrf2/HMOX-1 Pathway.
Ajibare AJ; Akintoye OO; Famurewa AC; Folawiyo MA; Bamisi OD; Asuku AO; Oyegbola OE; Akintayo CO; Olofinbiyi BA; Omotuyi OI
J Med Food; 2023 Sep; 26(9):683-691. PubMed ID: 38084993
[TBL] [Abstract][Full Text] [Related]
10. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
[TBL] [Abstract][Full Text] [Related]
11. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
Patel R; Shah G
Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
[TBL] [Abstract][Full Text] [Related]
12. Thuja occidentalis L. and its active compound, α-thujone: Promising effects in the treatment of polycystic ovary syndrome without inducing osteoporosis.
Küpeli Akkol E; İlhan M; Ayşe Demirel M; Keleş H; Tümen I; Süntar İ
J Ethnopharmacol; 2015 Jun; 168():25-30. PubMed ID: 25818694
[TBL] [Abstract][Full Text] [Related]
13. [Study on the oxidative stress in the ovaries of a rat model of polycystic ovary].
Gong J; Wu DB; Zhang LL; Li J; Zhao X; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):238-42, 247. PubMed ID: 25924437
[TBL] [Abstract][Full Text] [Related]
14. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
15. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
17. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.
Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M
Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958
[TBL] [Abstract][Full Text] [Related]
18. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Rajan RK; M SS; Balaji B
Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
[TBL] [Abstract][Full Text] [Related]
20. Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP-1 and VEGF: A histological, immunohistochemical, and biochemical study.
Shalaby AM; Shalaby RH; Elshamy AM; Alnasser SM; Alorini M; Jaber FA; Alabiad MA; Alshaikh ABA; Hassan SMA; Aziz SAMA; Safa MA; Elkholy MR
Cell Biochem Funct; 2024 Jun; 42(4):e4073. PubMed ID: 38863227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
